For the year ending 2025-12-31, OVID made $7,252K in revenue. -$17,414K in net income. Net profit margin of -240.13%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 7,252 | |||
| Payroll and payroll-related expenses | 7,765 | |||
| Total direct program expenses | 15,726 | |||
| Other research and development expenses | 2,091 | |||
| Research and development | 25,582 | |||
| General and administrative | 24,109 | |||
| Total operating expenses | 49,691 | |||
| Loss from operations | -42,439 | |||
| Other income (expense), net | 25,026 | |||
| Loss before provision for income taxes | -17,414 | |||
| Provision for income taxes | 0 | |||
| Net loss | -17,414 | |||
| Basic EPS | -232.47 | |||
| Diluted EPS | -232.47 | |||
| Basic Average Shares | 1,171 | |||
| Diluted Average Shares | 1,171 | |||
Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID)